Although desmoid tumors do not metastasize, they can be associated with recurrence rates of up to 77% after surgical ...
Long-term continuous OGSIVEO treatment for up to 4 years was associated with further tumor size reductions, increase in objective response rate, sustained improvement in desmoid tumor symptoms and con ...